Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
optimark sisaldab toimeainet gadoversetamiidi.
optimark contains the active substance gadoversetamide.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
gadoversetamiidi kasutatakse kontrastsuse suurendamiseks magnetresonantsuuringutes.
gadoversetamide is used as a ‘contrast agent’ in magnetic resonance imaging.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
iga 20 ml süstel sisaldab 6618 mg gadoversetamiidi.
each 20 ml syringe contains 6618 mg gadoversetamide.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
kui te olete allergiline : toimeaine gadoversetamiidi või
if you are allergic
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
gadoversetamiidi eritumisastet rinnapiima ei ole inimestel uuritud.
the degree of excretion of gadoversetamide in breast milk has not been studied in humans.
Last Update: 2012-04-11
Usage Frequency: 6
Quality:
optimark on süstelahus, mis sisaldab toimeainena gadoversetamiidi.
optimark is a solution for injection that contains the active substance gadoversetamide.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
andmed gadoversetamiidi eritumisest loomade piima on puudulikud.
there is insufficient information on the excretion of gadoversetamide in animal milk.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
gadoversetamiidi kasutamise kohta rasedatel kliiniline kogemus puudub.
there is no clinical experience with the use of gadoversetamide during pregnancy.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
jaotumine gadoversetamiidi farmakokineetika järgib kahe ruumi avatud mudelit.
distribution the pharmacokinetics of gadoversetamide conforms to a two compartment open-model.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
1 ml sisaldab 330,9 mg gadoversetamiidi, mis on ekvivalentne 500 mikromooliga.
1 ml contains 330.9 mg gadoversetamide, equivalent to 500 micromol.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
iga 10 ml süstel sisaldab 3309 mg gadoversetamiidi, mis on ekvivalentne 5 millimooliga.
each 10 ml syringe contains 3309 mg gadoversetamide equivalent to 5 millimol.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
seetõttu on alust arvata, et selles annustevahemikus on gadoversetamiidi kineetika lineaarne.
therefore, within this dose range, the kinetics of gadoversetamide appear to be linear.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
kuna gadoversetamiidi manustatakse ainult üksikannusena, on ekspositsiooni suurenemine ja pikenemine ajutise kestusega.
since gadoversetamide is only administered as a single dose this will lead to a longer and higher exposure for a limited duration.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Ülitundlikkus gadoversetamiidi või ravimi ükskõik millise abiaine või muude gadoliiniumi sisaldavate toodete suhtes.
hypersensitivity to gadoversetamide or to any of the excipients or to other gadolinium containing products.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
gadoversetamiidi on inimestel testitud annustes kuni 700 mikromooli/kg (seitsmekordne standardannus).
gadoversetamide has been tested in humans in doses up to 700 micromol/kg (seven times the standard dose).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Ülitundlikkus gadoversetamiidi või muude gadoliiniumi sisaldavate toodete või lõigus 6.1 loetletud mis tahes abiainete suhtes.
hypersensitivity to gadoversetamide or to other gadolinium containing products, or to any of the excipients listed in section 6.1.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kuna suurem osa gadoversetamiidi annusest on uriinis tuvastatav muutumatu kompleksina, viitab see märkimisväärse metaboliseerumise puudumisele inimesel.
the high accountability for the dose as intact complex in urine suggests that no significant metabolism of gadoversetamide occurs in humans.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
gadoversetamiidi olemasolul annab ocp-meetod plasma kaltsiumi mõõtmisel väära (madala) tulemuse.
in the presence of gadoversetamide, the ocp technique produces an erroneous, low value for plasma calcium.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
optimark’i ei tohi kasutada raseduse ajal, väljaarvatud juhul, kui naise kliiniline seisund vajab gadoversetamiidi kasutamist.
optimark should not be used during pregnancy unless the clinical condition of the woman requires use of gadoversetamide.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
aju- vere barjääri kahjustuse olemasolul difundeeruvad gadoversetamiidi molekulid interstitsiaalruumi, põhjustades seeläbi iseloomuliku paramagnetilise efekti t1 ja t2 lühenemise näol.
when the bbb is disrupted, the gadoversetamide molecules diffuse into the interstitial compartment thereby producing the characteristic paramagnetic effect of t1 and t2 shortening.
Last Update: 2012-04-11
Usage Frequency: 2
Quality: